Completed PHASE4 INTERVENTIONAL 2-arm NCT00927004

Efficacy of Etoricoxib 60 mg in Modifying Pain Hypersensitivity in People With Knee Osteoarthritis

A Randomised Placebo-controlled Trail of Mechanical and Cold Hyperalgesia in Subjects With Painful Knee Osteoarthritis, Compared With Matched Controls, & Whether This Hyperalgesia Can be Modified by a 2-week Course of Etoricoxib 60mg.

Sponsor: Curtin University

Conditions Osteoarthritis Pain

Interventions Etoricoxib (Arcoxia) Sugar pill

Updated 8 times since 2017 Last updated: May 1, 2012 Started: Aug 31, 2010 Primary completion: Nov 30, 2011 Completion: Dec 31, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Osteoarthritis and Pain, this trial is completed. The trial is conducted by Curtin University and has accumulated 8 data snapshots since 2010. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jun 2022 — Jul 2024 [monthly]

Completed PHASE4
Jan 2021 — Jun 2022 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4

▶ Show 3 earlier versions

May 2017 — Jun 2018 [monthly]

Completed PHASE4
Feb 2017 — May 2017 [monthly]

Completed PHASE4
Jan 2017 — Feb 2017 [monthly]

Completed PHASE4

First recorded

Aug 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Curtin University
Merck Sharp & Dohme LLC

Data source: Curtin University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Perth, Australia